ClinConnect ClinConnect Logo
Search / Trial NCT05675332

Effects of Stereotype Threat on Impulsivity and Its Relation to Alcohol Use in African Americans: An fMRI Study

Launched by ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · Dec 22, 2022

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is looking at how feelings of stress, caused by societal expectations, can affect impulsive behavior and alcohol use in African Americans. Researchers want to understand how stress impacts the brain and behavior, which could help improve our understanding of drinking habits in different communities.

To participate in the study, you need to be between 21 and 35 years old, speak English fluently, and be right-handed. If you join, you’ll undergo brain scans while completing tasks related to stress and decision-making. The study is currently recruiting participants, and it aims to shed light on important connections between stress, impulsivity, and alcohol use. Your involvement could help contribute to valuable insights in this area.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Between 21 and 35 years of age (inclusive);
  • Fluent in English;
  • Right-handed
  • Exclusion Criteria:
  • Younger than 21 years of age;
  • Left-handed

About Icahn School Of Medicine At Mount Sinai

The Icahn School of Medicine at Mount Sinai is a premier academic institution located in New York City, renowned for its commitment to advancing medical research, education, and patient care. As a leading sponsor of clinical trials, the institution leverages its state-of-the-art facilities and multidisciplinary expertise to drive innovative research initiatives aimed at improving health outcomes. With a focus on translational medicine, the Icahn School of Medicine collaborates with a diverse network of researchers, clinicians, and industry partners to explore novel therapies and interventions across a wide range of medical disciplines. Its rigorous scientific approach and dedication to ethical standards position it as a trusted leader in the clinical research landscape.

Locations

New York, New York, United States

Patients applied

0 patients applied

Trial Officials

Uraina Clark, PhD

Principal Investigator

Icahn School of Medicine at Mount Sinai

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials